Neovascularization
Showing 1 - 25 of 1,176
Impact of Non-Exudative Type 1 MNV on AMD Progression
Recruiting
- Age-Related Macular Degeneration
- Neovascularization, Choroidal
-
Salt Lake City, UtahUniversity of Utah
Nov 15, 2023
Novel Subset of Neutrophil and Corneal Neovascularization.
Not yet recruiting
- Corneal Neovascularization
- Neutrophils
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Dec 13, 2022
Deep Learning OCT and OCTA in NVC
Recruiting
- Macular Degeneration Choroidal Neovascularization
- Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter
-
Naples, ItalyFederico II University
Aug 3, 2023
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
Recruiting
- Polypoidal Choroidal Vasculopathy
- +2 more
- Intravitreal aflibercept injection
-
Seoul, Korea, Republic ofJae Hui Kim
Dec 20, 2022
Corneal Neovascularization Trial in Indianapolis (30 minute photoactivation of riboflavin 0.1%, 10 minute photoactivation of
Recruiting
- Corneal Neovascularization
- 30 minute photoactivation of riboflavin 0.1%
- 10 minute photoactivation of riboflavin 0.1%
-
Indianapolis, IndianaPrice Vision Group
Jul 27, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- BD311
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Aug 22, 2022
Subjects Diagnosed With Neovascular-AMD
Recruiting
- Retinal Neovascularization
-
Boston, Massachusetts
- +2 more
Dec 6, 2022
Learn More About How Drug Aflibercept Works in Canadian Reduced
Active, not recruiting
- Myopic Choroidal Neovascularization
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, CanadaMany Locations
Jul 25, 2022
Age-Related Macular Degeneration, Choroidal Neovascularization, Genetic Counseling Trial in Salt Lake City (Early disclosure,
Completed
- Age-Related Macular Degeneration
- +2 more
- Early disclosure
- Late disclosure
-
Salt Lake City, UtahUniversity of Utah John A. Moran Eye Center
Aug 10, 2022
Pathologic Myopia Trial in Mykolaiv, Odessa (Intravitreal injection)
Completed
- Pathologic Myopia
- Intravitreal injection
-
Mykolaiv, Ukraine
- +2 more
Jan 23, 2023
Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial
Recruiting
- Diabetic Macular Edema
- +4 more
- Anti-vascular endothelial growth factors (Anti-VEGFs)
-
Banhā, Benha, EgyptAhmed Abdelshafy Tabl
Aug 8, 2022
Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia
Not yet recruiting
- Macular Degeneration, Age Related
- +4 more
- VISUPRIME
- Placebo
-
Perugia, PG, ItalyOspedale Santa Maria della Misericordia
Dec 22, 2022
Choroidal Neovascularization Trial in Sao Paulo (bevacizumab)
Completed
- Choroidal Neovascularization
-
Sao Paulo, BrazilHospital das Clínicas- University of Sao Paulo
Jan 4, 2022
Carotid Intraplaque Neovascularization Combined With Stress Echo
Recruiting
- Atherosclerosis
- +5 more
- Carotid Contrast Enhanced Ultrasound
-
Calgary, Alberta, Canada
- +3 more
Jun 8, 2022
Carotid Stenosis Trial (Optical coherence tomography angiography and pattern electroretinogram)
Not yet recruiting
- Carotid Stenosis
- Optical coherence tomography angiography and pattern electroretinogram
- (no location specified)
Apr 19, 2023
Real Life Study in Myopic Neovascularization
Active, not recruiting
- Myopic Choroidal Neovascularisation
- AFLIBERCEPT
-
Poitiers, FranceChu de Poitiers
Sep 28, 2021
Dark Halo and MNV: a Study Between ICGA and OCTA
Completed
- Macular Neovascularisation
- Optical Coherence Tomography Angiography (OCTA) and indocyanine green angiography (ICGA)
-
Naples, ItalyUniversity of Naples "Federico II"
Nov 16, 2021
Macular Degeneration, Choroidal Neovascularization Trial in 'Aiea, Oak Forest (episcleral brachytherapy)
Recruiting
- Macular Degeneration, Choroidal Neovascularization
- episcleral brachytherapy
-
'Aiea, Hawaii
- +1 more
Feb 11, 2022
Safety, Tolerability and Pharmacokinetic Profile in Healthy Volunteers, Choroidal Neovascularization Trial in Madrid (SYL18001
Completed
- Safety, Tolerability and Pharmacokinetic Profile in Healthy Volunteers
- Choroidal Neovascularization
- SYL18001 sodium Low dose q.d
- +3 more
-
Madrid, SpainSylentis Clinical Trial Site
Mar 30, 2022
Corneal Neovascularization Trial in Guangzhou (KDR2-2 suspension eye drops)
Recruiting
- Corneal Neovascularization
- KDR2-2 suspension eye drops
-
Guangzhou, Guangdong, China
- +1 more
Aug 17, 2021
Carotid Stenosis, Carotid Artery Diseases, Carotid Atherosclerosis Trial in Paris (contrast enhanced ultrafast ultrasound
Recruiting
- Carotid Stenosis
- +4 more
- contrast enhanced ultrafast ultrasound imaging
-
Paris, FranceHopital europeen Georges-Pompidou
Nov 15, 2021
Ischemic Stroke, Neovascularization Trial in Belgium, Germany, United States (Tigertriever 13)
Recruiting
- Ischemic Stroke
- Neovascularization
- Tigertriever 13
-
Thousand Oaks, California
- +5 more
Jul 5, 2022
Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.
Completed
- Retinal Neovascularization
-
Boston, Massachusetts
- +1 more
Nov 25, 2021
In Vivo Depiction Of Bone Vascularization With UHR-CT CT And
Not yet recruiting
- Bone Vascular Tumor
- CT
- (no location specified)
Nov 23, 2022